Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND3 pseudogene 9 (MTND3P9) is a human pseudogene located on chromosome 2q22.2, annotated as a non-functional genomic sequence related to the mitochondrial MT-ND3 gene, which encodes the NADH:ubiquinone oxidoreductase core subunit 3 of the mitochondrial respiratory chain Complex I. As a pseudogene, MTND3P9 does not encode a functional protein and is not involved in known biological or pathological processes, nor does it serve as a direct drug target[2][4][6][8]. Key context: - This entity is not a therapeutic target, receptor, enzyme, or transporter, as it is classified as a pseudogene, meaning it is a non-functional remnant of a gene[6][8]. - There are no described biological functions, disease involvements, drug interactions, or mechanisms of action for this pseudogene. - MTND3P9 is often listed in genomic databases (GeneCards, NCBI, HGNC) as a pseudogene with no protein product, no clinical significance, and no established research utility at present[2][6][8]. - The functional gene, MT-ND3, should not be confused with MTND3P9. MT-ND3 encodes an essential mitochondrial enzyme subunit, but MTND3P9 does not encode protein or have described function[3][7][9]. Summary of core information: - MTND3P9 is a pseudogene and not an active molecular target; major databases confirm lack of function or relevance as any canonical therapeutic gene or protein[2][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND3 pseudogene 9 (MTND3P9).